Skip to main content

Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients

The Original Article was published on 18 August 2020

Correction to: Breast Cancer Research (2020) 22:91 https://doi.org/10.1186/s13058-020-01328-0

Following publication of the original article [1], the authors identified some errors in Fig. 4. The correct figure is given below.

Fig. 4
figure 4

Prognostic associations in this cohort of sequenced metastatic breast cancer patients. a Overall survival by subtype for all recruited patients (n = 323). b Overall survival of patients based on the mutational burden of 4 mutations (75th percentile) or more (n = 234). c Overall survival of ER + HER2 − patients based on the median mutation number of 4 or more (n = 163 patients). d Table of HR for all patients and all subtypes by mutation number per sample. Patients were excluded if there was incomplete survival information. e Spread of TILs across distant metastatic site (n = 123)

The original article [1] has been corrected.

Reference

  1. van Geelen CT, Savas P, Teo ZL, Luen SJ, Weng C-F, Ko Y-A, Kuykhoven KS, Caramia F, Salgado R, Francis PA, Dawson S-J, Fox SB, Fellowes A, Loi S. Clinical implications of prospective genomic profiling of metastatic breast cancer patients. Breast Cancer Res. 2020;22:91. https://doi.org/10.1186/s13058-020-01328-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sherene Loi.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

van Geelen, C.T., Savas, P., Teo, Z.L. et al. Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients. Breast Cancer Res 24, 50 (2022). https://doi.org/10.1186/s13058-022-01539-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13058-022-01539-7